PubRank

Hironobu Ohmatsu

Author PubWeight™ 44.64‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Screening for lung cancer with low-dose helical computed tomography: anti-lung cancer association project. J Clin Oncol 2002 2.18
2 Irinotecan pharmacokinetics/pharmacodynamics and UGT1A genetic polymorphisms in Japanese: roles of UGT1A1*6 and *28. Pharmacogenet Genomics 2007 2.01
3 Limited resection trial for pulmonary ground-glass opacity nodules: fifty-case experience. J Thorac Cardiovasc Surg 2005 1.70
4 First-line single agent treatment with gefitinib in patients with advanced non-small-cell lung cancer: a phase II study. J Clin Oncol 2006 1.49
5 Severe interstitial lung disease associated with amrubicin treatment. J Thorac Oncol 2010 1.48
6 Mutational status of EGFR and KIT in thymoma and thymic carcinoma. Lung Cancer 2008 1.21
7 Therapeutic priority of the PI3K/AKT/mTOR pathway in small cell lung cancers as revealed by a comprehensive genomic analysis. J Thorac Oncol 2014 1.19
8 Hypertrophic pulmonary osteoarthropathy as a paraneoplastic manifestation of lung cancer. J Thorac Oncol 2010 1.15
9 Progression of focal pure ground-glass opacity detected by low-dose helical computed tomography screening for lung cancer. J Comput Assist Tomogr 2004 1.13
10 Weekly chemotherapy with cisplatin, vincristine, doxorubicin, and etoposide is an effective treatment for advanced thymic carcinoma. Cancer 2003 1.07
11 Comparison of pharmacokinetics and pharmacodynamics of docetaxel and Cisplatin in elderly and non-elderly patients: why is toxicity increased in elderly patients? J Clin Oncol 2004 1.02
12 Concurrent chemoradiotherapy with cisplatin and vinorelbine for stage III non-small cell lung cancer. J Thorac Oncol 2008 1.01
13 Performance status and sensitivity to first-line chemotherapy are significant prognostic factors in patients with recurrent small cell lung cancer receiving second-line chemotherapy. Cancer 2008 0.97
14 Quantitative classification based on CT histogram analysis of non-small cell lung cancer: correlation with histopathological characteristics and recurrence-free survival. Med Phys 2012 0.95
15 Re-challenge chemotherapy for relapsed non-small-cell lung cancer. Lung Cancer 2010 0.90
16 Randomized trial of drip infusion versus bolus injection of vinorelbine for the control of local venous toxicity. Lung Cancer 2006 0.89
17 Characterization of the immunophenotype of the tumor budding and its prognostic implications in squamous cell carcinoma of the lung. Lung Cancer 2011 0.89
18 Solid predominant histology predicts EGFR tyrosine kinase inhibitor response in patients with EGFR mutation-positive lung adenocarcinoma. J Cancer Res Clin Oncol 2013 0.88
19 Renal toxicity caused by brand-name versus generic cisplatin: a comparative analysis. Jpn J Clin Oncol 2013 0.88
20 Detection of unsuspected distant metastases and/or regional nodes by FDG-PET [corrected] scan in apparent limited-disease small-cell lung cancer. Lung Cancer 2007 0.88
21 Performance evaluation of 4 measuring methods of ground-glass opacities for predicting the 5-year relapse-free survival of patients with peripheral nonsmall cell lung cancer: a multicenter study. J Comput Assist Tomogr 2008 0.87
22 Clinical features of unresectable high-grade lung neuroendocrine carcinoma diagnosed using biopsy specimens. Lung Cancer 2011 0.86
23 High body mass index correlates with increased risk of venous irritation by vinorelbine infusion. Jpn J Clin Oncol 2004 0.86
24 Example-based assisting approach for pulmonary nodule classification in three-dimensional thoracic computed tomography images. Acad Radiol 2003 0.86
25 Protective effect of magnesium preloading on cisplatin-induced nephrotoxicity: a retrospective study. Jpn J Clin Oncol 2014 0.86
26 Risk factors associated with fatal pulmonary hemorrhage in locally advanced non-small cell lung cancer treated with chemoradiotherapy. BMC Cancer 2012 0.83
27 Identification of prognostic immunophenotypic features in cancer stromal cells of high-grade neuroendocrine carcinomas of the lung. J Cancer Res Clin Oncol 2013 0.83
28 Aldehyde dehydrogenase 1 expression in cancer cells could have prognostic value for patients with non-small cell lung cancer who are treated with neoadjuvant therapy: identification of prognostic microenvironmental factors after chemoradiation. Pathol Int 2013 0.81
29 Interstitial shadow on chest CT is associated with the onset of interstitial lung disease caused by chemotherapeutic drugs. Jpn J Clin Oncol 2006 0.81
30 Calcification in large cell neuroendocrine carcinoma of the lung. Jpn J Clin Oncol 2003 0.81
31 Phase II study of docetaxel and cisplatin administered as three consecutive weekly infusions for advanced non-small cell lung cancer. Lung Cancer 2002 0.81
32 Influence of slice thickness on diagnoses of pulmonary nodules using low-dose CT: potential dependence of detection and diagnostic agreement on features and location of nodule. Acad Radiol 2011 0.80
33 Clinical outcome of small cell lung cancer with pericardial effusion but without distant metastasis. J Thorac Oncol 2011 0.80
34 Development of Cushing's syndrome during effective chemotherapy for small cell lung cancer. Intern Med 2011 0.80
35 Feasibility study of zoledronic acid plus cisplatin-docetaxel as first-line treatment for advanced non-small cell lung cancer with bone metastases. Anticancer Res 2012 0.79
36 Meta-analysis of epoetin beta and darbepoetin alfa treatment for chemotherapy-induced anemia and mortality: Individual patient data from Japanese randomized, placebo-controlled trials. Cancer Sci 2013 0.79
37 Randomized trial of oral versus intravenous antibiotics in low-risk febrile neutropenic patients with lung cancer. Jpn J Clin Oncol 2004 0.79
38 Efficacy and safety of weekly nab-paclitaxel plus carboplatin in patients with advanced non-small cell lung cancer. Lung Cancer 2013 0.78
39 The adenocarcinoma-specific stage shift in the Anti-lung Cancer Association project: significance of repeated screening for lung cancer for more than 5 years with low-dose helical computed tomography in a high-risk cohort. Lung Cancer 2009 0.78
40 Trends in chemotherapy for elderly patients with advanced non-small-cell lung cancer. Respir Med 2009 0.78
41 Comparison of the expression levels of molecular markers among the peripheral area and central area of primary tumor and metastatic lymph node tumor in patients with squamous cell carcinoma of the lung. J Cancer Res Clin Oncol 2015 0.78
42 Combination second-line chemotherapy with gemcitabine and docetaxel for recurrent non-small-cell lung cancer after platinum-containing chemotherapy: a phase I/II trial. Cancer Chemother Pharmacol 2003 0.77
43 Second-line docetaxel for patients with platinum-refractory advanced non-small cell lung cancer and interstitial pneumonia. Cancer Chemother Pharmacol 2015 0.77
44 Clinical outcome of chemoradiation therapy in patients with limited-disease small cell lung cancer with ipsilateral pleural effusion. J Thorac Oncol 2008 0.77
45 Safety and efficacy of platinum agents plus etoposide for patients with small cell lung cancer with interstitial lung disease. Anticancer Res 2013 0.76
46 Presence of podoplanin-positive cancer-associated fibroblasts in surgically resected primary lung adenocarcinoma predicts a shorter progression-free survival period in patients with recurrences who received platinum-based chemotherapy. J Cancer Res Clin Oncol 2014 0.76
47 Three novel single nucleotide polymorphisms in UGT1A10. Drug Metab Pharmacokinet 2002 0.75
48 Previously reported lung cancer growth curves. Chest 2010 0.75
49 Phase II trial of carboplatin and paclitaxel in non-small cell lung cancer patients previously treated with chemotherapy. Lung Cancer 2007 0.75
50 A phase II study of hyperfractionated accelerated radiotherapy (HART) after induction cisplatin (CDDP) and vinorelbine (VNR) for stage III non-small-cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys 2005 0.75
51 Cushing's syndrome associated with adenocarcinoma of the lung. Intern Med 2003 0.75
52 Dose-Escalation Study of Thoracic Radiotherapy in Combination With Pemetrexed Plus Cisplatin in Japanese Patients With Locally Advanced Nonsquamous Non-Small Cell Lung Cancer: A Post Hoc Analysis of Survival and Recurrent Sites. Am J Clin Oncol 2016 0.75
53 A method for determining the modulation transfer function from thick microwire profiles measured with x-ray microcomputed tomography. Med Phys 2012 0.75
54 [A Report on the JSMP 109 Symposium 2 "How Could We Contribute in Reducing the Lung Cancer Mortality?: Facing to CMS Decision for Lung Cancer with Low Dose CT Screening"]. Igaku Butsuri 2015 0.75
55 A phase I study of gemcitabine and carboplatin in patients with advanced non-small cell lung cancer and a performance status of 2. Jpn J Clin Oncol 2009 0.75